255 related articles for article (PubMed ID: 9400787)
21. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28.
Collaborative Ocular Melanoma Study Group
Arch Ophthalmol; 2006 Dec; 124(12):1684-93. PubMed ID: 17159027
[TBL] [Abstract][Full Text] [Related]
22. I-125 brachytherapy for choroidal melanoma photographic and angiographic abnormalities: the Collaborative Ocular Melanoma Study: COMS Report No. 30.
Boldt HC; Melia BM; Liu JC; Reynolds SM;
Ophthalmology; 2009 Jan; 116(1):106-115.e1. PubMed ID: 19118701
[TBL] [Abstract][Full Text] [Related]
23. Small choroidal melanoma: outcomes following apical height dose brachytherapy.
Yupari RJ; Bena J; Wilkinson A; Suh J; Singh A
Br J Ophthalmol; 2021 Aug; 105(8):1161-1165. PubMed ID: 32878827
[TBL] [Abstract][Full Text] [Related]
24. Golden Jubilee Lecture. Randomised clinical trials of choroidal melanoma treatment.
Straatsma BR
Indian J Ophthalmol; 2003 Mar; 51(1):17-23. PubMed ID: 12701858
[TBL] [Abstract][Full Text] [Related]
25. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26.
Diener-West M; Reynolds SM; Agugliaro DJ; Caldwell R; Cumming K; Earle JD; Hawkins BS; Hayman JA; Jaiyesimi I; Jampol LM; Kirkwood JM; Koh WJ; Robertson DM; Shaw JM; Straatsma BR; Thoma J;
Arch Ophthalmol; 2005 Dec; 123(12):1639-43. PubMed ID: 16344433
[TBL] [Abstract][Full Text] [Related]
26. Prescribing to tumor apex in episcleral plaque iodine-125 brachytherapy for medium-sized choroidal melanoma: A single-institutional retrospective review.
Vonk DT; Kim Y; Javid C; Gordon JD; Stea B
Brachytherapy; 2015; 14(5):726-33. PubMed ID: 26051804
[TBL] [Abstract][Full Text] [Related]
27. Ruthenium-106 versus iodine-125 plaque brachytherapy of 571 choroidal melanomas with a thickness of ≥5.5 mm.
Filì M; Trocme E; Bergman L; See TRO; André H; Bartuma K; Girnita L; All-Eriksson C; Seregard S; Stålhammar G
Br J Ophthalmol; 2020 Jan; 104(1):26-32. PubMed ID: 30910871
[TBL] [Abstract][Full Text] [Related]
28. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma III: local complications and observations following enucleation COMS report no. 11.
Am J Ophthalmol; 1998 Sep; 126(3):362-72. PubMed ID: 9744369
[TBL] [Abstract][Full Text] [Related]
29. Choroidal melanoma: a review and case report.
Cymbor MJ; Check JM
J Am Optom Assoc; 1998 Oct; 69(10):656-65. PubMed ID: 9805447
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of iodine 125 plaque radiotherapy after initial observation of suspected small choroidal melanomas: a pilot study.
Sobrin L; Schiffman JC; Markoe AM; Murray TG
Ophthalmology; 2005 Oct; 112(10):1777-83. PubMed ID: 16095708
[TBL] [Abstract][Full Text] [Related]
31. Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15.
Collaborative Ocular Melanoma Study Group.
Arch Ophthalmol; 2001 May; 119(5):670-6. PubMed ID: 11346394
[TBL] [Abstract][Full Text] [Related]
32. Mortality after deferral of treatment or no treatment for choroidal melanoma.
Straatsma BR; Diener-West M; Caldwell R; Engstrom RE;
Indian J Ophthalmol; 2018 Oct; 66(10):1395-1400. PubMed ID: 30249822
[TBL] [Abstract][Full Text] [Related]
33. Comparison of clinical, echographic, and histopathological measurements from eyes with medium-sized choroidal melanoma in the collaborative ocular melanoma study: COMS report no. 21.
Collaborative Ocular Melanoma Study Group
Arch Ophthalmol; 2003 Aug; 121(8):1163-71. PubMed ID: 12912695
[TBL] [Abstract][Full Text] [Related]
34. Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement.
Gündüz K; Shields CL; Shields JA; Cater J; Freire JE; Brady LW
Am J Ophthalmol; 1999 May; 127(5):579-89. PubMed ID: 10334352
[TBL] [Abstract][Full Text] [Related]
35. Changing concepts in the management of choroidal melanoma.
Robertson DM
Am J Ophthalmol; 2003 Jul; 136(1):161-70. PubMed ID: 12834684
[TBL] [Abstract][Full Text] [Related]
36. Histopathologic characteristics of uveal melanomas in eyes enucleated from the Collaborative Ocular Melanoma Study. COMS report no. 6.
Am J Ophthalmol; 1998 Jun; 125(6):745-66. PubMed ID: 9645714
[TBL] [Abstract][Full Text] [Related]
37. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
[TBL] [Abstract][Full Text] [Related]
38. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.
Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL
Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224
[TBL] [Abstract][Full Text] [Related]
39. Dosimetric and radiobiologic comparison of
Gorovets D; Gagne NL; Melhus CS
Brachytherapy; 2017; 16(2):433-443. PubMed ID: 28161431
[TBL] [Abstract][Full Text] [Related]
40. Survival implications of enucleation after definitive radiotherapy for choroidal melanoma: an example of regression on time-dependent covariates.
Egan KM; Ryan LM; Gragoudas ES
Arch Ophthalmol; 1998 Mar; 116(3):366-70. PubMed ID: 9514491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
